ITCMDBv1
Clinical TrialID 447

Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia

NCT04252131

Schizophrenia

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
447
Evidence Id
447
Core Evidence Id
447
Source Clinical Trial Id
433
Herb2 Clinical Trial Id
HBCT000433
Nct Id
NCT04252131
Title
Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Schizophrenia
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Intervention
DRUG: cassia seed tablet
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
92
Outcome Measure
physiological parameter for measuring Height and weight, the parameter of BMI in kg/m\^2 for exploring the changes of body mass index (BMI) after cassia obtusifolia treatment, 12 weeks|sphygmomanometer, the parameter of systolic blood pressure and diastolic blood pressure after cassia obtusifolia treatment, 12 weeks
Sponsor Collaborator
Calo Psychiatric Center
Funded By
OTHER
Location
Calo Psychiatric Center, Pingtung, Others, 925, Taiwan
Other Id
106-046
Start Date
2018-05-17
Primary Completion Date
2019-10-31
Completion Date
2019-10-31
First Posted
2020-02-05
Results First Posted
Last Update Posted
2020-02-05
Study Document
Study Url
https://clinicaltrials.gov/study/NCT04252131
Title Cn
Title En
Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia
Bilingual Status
semi_complete